Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Placement Agency Agreement
- 4.10 Form of Pre-funded Warrant
- 4.11 Form of Series a Common Warrant
- 4.12 Form of Series B Common Warrant
- 5.1 Opinion of Lewis Brisbois Bisgaard & Smith LLP
- 10.61 Form of Securities Purchase Agreement
- 23.1 Consent of Wolf & Company, P.C
- EX-FILING FEES Calculation of Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
ALLR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement (No. 333-275224) on Form S-1 and related Prospectus of Allarity Therapeutics, Inc. of our report dated March 9, 2023, relating to the consolidated financial statements of Allarity Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Allarity Therapeutics, Inc. for the year ended December 31, 2022.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
December 4, 2023